These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23202257)

  • 1. Health expenditure growth: looking beyond the average through decomposition of the full distribution.
    de Meijer C; O'Donnell O; Koopmanschap M; van Doorslaer E
    J Health Econ; 2013 Jan; 32(1):88-105. PubMed ID: 23202257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impotence of price controls: failed attempts to constrain pharmaceutical expenditures in Greece.
    Lambrelli D; O'Donnell O
    Health Policy; 2011 Jul; 101(2):162-71. PubMed ID: 20884073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of newer drugs on health spending: do they really increase the costs?
    Civan A; Köksal B
    Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DRG-based hospital payment systems and technological innovation in 12 European countries.
    Scheller-Kreinsen D; Quentin W; Busse R
    Value Health; 2011 Dec; 14(8):1166-72. PubMed ID: 22152189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous cost-effectiveness analysis and health care technology adoption.
    Jena AB; Philipson TJ
    J Health Econ; 2013 Jan; 32(1):172-80. PubMed ID: 23202262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term persistence of high health care costs in a nationally representative sample of children.
    Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
    Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription drugs and the changing concentration of health care expenditures.
    Zuvekas SH; Cohen JW
    Health Aff (Millwood); 2007; 26(1):249-57. PubMed ID: 17211035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22619775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Explaining high health care spending in the United States: an international comparison of supply, utilization, prices, and quality.
    Squires DA
    Issue Brief (Commonw Fund); 2012 May; 10():1-14. PubMed ID: 22582452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the costs of psychiatric hospital services at a public health facility in Nigeria.
    Ezenduka C; Ichoku H; Ochonma O
    J Ment Health Policy Econ; 2012 Sep; 15(3):139-48. PubMed ID: 23001282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explaining health care expenditure variation: large-sample evidence using linked survey and health administrative data.
    Ellis RP; Fiebig DG; Johar M; Jones G; Savage E
    Health Econ; 2013 Sep; 22(9):1093-110. PubMed ID: 23494838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.
    Bozzette SA; Joyce G; McCaffrey DF; Leibowitz AA; Morton SC; Berry SH; Rastegar A; Timberlake D; Shapiro MF; Goldman DP;
    N Engl J Med; 2001 Mar; 344(11):817-23. PubMed ID: 11248159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of factors affecting pharmaceutical expenditures.
    Mousnad MA; Shafie AA; Ibrahim MI
    Health Policy; 2014 Jun; 116(2-3):137-46. PubMed ID: 24726509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hungary health system review.
    Gaal P; Szigeti S; Csere M; Gaskins M; Panteli D
    Health Syst Transit; 2011; 13(5):1-266. PubMed ID: 22394651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.